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Steady state fluorescence anisotropy (rJ of TMA-DPH was measured to study the effect of respiratory burst activation with PMA, FMLP, and 
PAF on the physico-chemical structure of PMNs plasma membrane. Our results show a significant increase in r, during the respiratory burst activa- 
tion. In the presence of NADPH-oxidase inhibitor DPI, only PAF induces changes in r, values. This suggests anon-specific effect of PAF on plasma 
membrane. Azide, which induces a supranormal release of HzOz, fails to increase the basal r, value after activation. Moreover, the catalase does 
not abolish the increase in r, induced upon activation. This rules out the possibility that changes of r, during the respiratory burst activation are 
attributed mainly to H,O, release. We conclude that multiple processes accompanying the respiratory burst activation are responsible for the 
changes in the physico-chemical properties of PMNs plasma membrane. 
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1. INTRODUCTION 
The activation of the respiratory burst (RB) is in- 
itiated by the stimulation of the membrane-bound 
NADPH oxidase system to generate superoxide anion 
(02 ) [ 11. This system is activated by a wide variety of 
stimuli [2]. The biochemical events following the ox- 
idase activation are multiple and complex, involving a 
number of processes which take place at the level of cell 
surface, plasma membrane and cytosol [2-61, Several 
modifications of the plasma membrane fluidity of 
PMNs have been described in association with the RB 
17-101. Fluidity is a complex physico-chemic~ feature 
which depends upon the mobility and order of mem- 
brane components [l 11. Changes in composition and 
molecular organization are the principal determinants 
inducing alterations in the physico-chemical structure 
of membrane. 
In this study we have investigated the changes of 
steady-state fluorescence anisotropy (rs) in PMNs dur- 
ing stimulation with various agents known to activate 
the RB. As fluorescent probe we have used 
l-(4-trimethyl~moniumphenyi)-6-phenyl-l,3,5-bexat- 
riene (TMA-DPH), which goes to the lipid-water inter- 
face region of the plasma membrane 1121, where it per- 
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sists for up to 30 min [ 131, enabling us to detect physico- 
chemical changes of plasma membrane in living cells 
during the RB activation. Measurements have also been 
performed in the presence of RB inhibitors. 
2. MATERIALS AND METHODS 
2.1. Preparation of PMNs 
Heparinised blood was obtained from 20 healthy non-smokers 
(18-30 years old) without any signs of acute infection or im- 
munological disorders. PMNs were isolated using a Mono-Poly 
Resolving Medium (Plow Laboratories) as previously described [14]. 
Cells were resuspended in Krebs-Ringer phosphate solution plus 1 
mg/ml glucose at a final concentration of lcr’ cells/ml and lo6 
cells/ml for chemiluminescence and fluorescence studies, respec- 
tively. 
2.2. Stimulating agents 
Phorbol myristate acetate (PMA), N-formyl-methionyl-leucyl- 
phenylalanine (FMLP) and 1-alkyl-2-acetyl-sn-glycero-3-phospho- 
choline (PAF) were obtained from Sigma Chemical Co. (St. Louis, 
MO, USA). 
2.3. Respiratory burst inhibitors 
Diphenyl iodonium (DPI) (50 mM), sodium azide (1 mM) and 
catalase (2tXlO U/ml) were purchased from Sigma. The inhibitors were 
added to PMNs before activation. 
2.4. ~hemiiami~esce~ce studies 
Luminol amplified chemiluminescence was measured in an LKB 
RackBeta 1211 beta-counter as previously described 1141. 
After measuring the basal chemiluminescence l vel for 15 min, 
PMNs were activated by addition of 1.5 x low6 M PMA, lo- ’ M 
FMLP, or lOA8 M PAF and the increase in chemiluminescence was 
followed for 20 min. 
2.5. Fluorescence studies 
Steady-state fluorescence anisotropy (rS) measurements were per- 
formed at 37°C with a Perkin Elmer Spectrofluorimeter MPF-66 
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Fig. 1. Luminol amplified chemiluminescence of PMNs activated 
with PAF in the presence and absence of DPI and azide. 
equipped with the Series 7000 Professional Computer for data ac- 
quisition, using TMA-DPH (Molecular Probes Inc., Eugene, OR, 
USA) as a hydrophobic fluorescent probe at a final concentration of 
10 - 6 M as previously described [7]. After incubation with TMA-DPH 
for 5 min PMNs were stimulated by addition of stimulating agents 
(1.5x10-6MPMA,10-5MFMLP,or10-8MPAF)intheabsence 
and presence of inhibitors and the fluorescence anisotropy was 
measured for 20 min. Data were analysed by Student’s t-test. 
3. RESULTS 
Luminol amplified chemiluminescence (CL) has been 
employed to verify that the superoxide-generating ox- 
idase system in separated PMNs is dormant under 
resting conditions and can be activated by PMA, FMLP 
and PAF. Moreover, the effects of DPI (50 PM), azide 
(1 mM) and catalase (2000 U/ml) on the CL of resting 
and activated PMNs have been tested. Our data demon- 
strate a 90% inhibition of CL by DPI and a 85% inhibi- 
tion by azide. No effect of catalase is observed. This is 
in accordance with our previous observations [14]. Fig. 
1 shows the CL measurements of PMNs activated by 
PAF in the absence and presence of DPI and azide. 
Fig. 2. Steady state fluorescence anisotropy (r.) of TMA-DPH at 
37°C in PMNs activated with PMA (A), FMLP (B), and PAF (C). 
Values are expressed as the mean + SD of 20 samples. The r increase 
after activation is significant (PcO.05). 
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Fig. 3. Steady state fluorescence anisotropy (rS) of TMA-DPH at 37% in PMNs activated with PMA in the Presence of DPI (A), a.zi& W, and 
catalase (C). Values are expressed as the mean f SD of 10 sampfes. 
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Fig. 4. Steady state fluorescence anisotropy (rJ of TMA-DPH at 37°C in PMNs activated with PAF in the presence of PDI. Values are expressed 
as the mean f SD of 10 samples. 
Activation of resting PMNs by PMA (Fig. 2A), 
FMLP (Fig. 2B) and PAF (Fig. 2C) causes a significant 
increase (PcO.05) of TMA-DPH r,. A lasting and 
stable increase in r, value is observed 3 min after addi- 
tion of PMA to resting PMNs. FMLP induces an in- 
crease in r, value that reaches a peak value 7 min after 
activation, returning to the basal value after 12 min. A 
rapid increase in rs value followed by a gradual decrease 
towards the basal value is observed after stimulation 
with PAF. 
The r, is not significantly changed after the addition 
of DPI to resting PMNs and after the consequent ac- 
tivation with PMA (Fig. 3A). However, using PAF as 
activator in the presence of DPI, a significant increase 
(PcO.05) of r, is observed (Fig. 4). Azide induces a 
transient increase of r, in resting PMNs. However, after 
activation with PMA no effect in rs is observed (Fig. 
3B). In the presence of catalase (2000 U/ml) a transient 
increase of r, is observed in resting PMNs and following 
activation with PMA (Fig. 3C). 
4. DISCUSSION 
The RB in PMNs can be activated by a variety of 
agents. Regardless of the stimulus used, the activation 
pathways converge at the NADPH oxidase system [ 151. 
This activation involves a number of biochemical events 
which occur at the level of the plasma membrane. In 
this study we have used as activators PMA, FMLP and 
PAF, which employ different stimulating pathways of 
oxidase activation and we have investigated the effect 
of these agents on the r, of PMNs plasma membrane. 
TMA-DPH r, of membranes reflects the packing of 
membrane lipid fatty acid chains and can be related to 
the order parameter S, if certain precautions are taken 
[16,17]. The lipid composition and therefore the pack- 
ing can change upon certain stimuli and this has been 
shown to modulate cell function [l&19]. Such specific 
effects could be mediated through local lipid packing 
constraints which would affect the membrane protein 
conformation and the exposition of membrane com- 
ponents [19,20]. In concomitance with the RB activa- 
tion we have observed physico-chemical changes of 
PMNs plasma membrane structure. The increase of r, 
upon stimulation indicates an increase in order of mem- 
brane lipid domains and may be due to various pro- 
cesses accompanying the RB activation [2-61. Since no 
changes of rs occur upon activation of PMNs with 
PMA in the presence of DPI, which inhibits NADPH 
oxidase, it seems likely that the observed r, changes are 
a consequence of NADPH oxidase activation. 
PAF induces an increase of rs of DPI-treated PMNs 
although the RB phenomenon is not activated as 
demonstrated by the chemiluminescence study. This is 
in accordance with recent observations of a non-specific 
effect of PAF on cell plasma membranes [21]. 
Recently a role of excited oxygen species, mainly 
H202, on the changes of the physico-chemical structure 
of PMNs plasma membrane has been proposed by 
Masuda et al. [lo]. It is known that in the presence of 
azide, which inhibits myeloperoxidase, a supranormal 
release of Hz02 by activated PMNs occurs [22]. Since 
our results have shown no changes of r, in azide treated 
PMNs after stimulation, it seems unlikely that the 
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above-reported increase of r, upon activation of PMNs 
by the stimuli is mainly due to H202. To further analyze 
the role of Hz02 on r, changes, we investigated the ef- 
fect of catalase on PMNs activation. Addition of 
catalase induces a transient increase of r, in resting 
PMNs and after stimulation with PMA. This supports 
the conclusion that Hz02 does not play a major role in 
r, changes during the RB activation. 
The increased order of the membrane lipid fatty acid 
chains accompan~ng RB activation, is not only related 
to the release of Hz02 but also to the various molecular 
events that occur during the RB. Further studies are in 
progress in our laboratory to explain and understand 
the mechanism which modulates the physico-chemical 
structure of the PMNs plasma membrane during activa- 
tion. 
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